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Edited by Lukas HuberAbstract Plakophilin 3 (PKP3) belongs to the p120ctn family
of armadillo-related proteins predominantly functioning in des-
mosome formation. Here we report that PKP3 is transcription-
ally repressed by the E-cadherin repressor ZEB1 in metastatic
cancer cells. ZEB1 physically associates with two conserved E-
box elements in the PKP3 promoter and partially represses the
activity of corresponding human and mouse PKP3 promoter
fragments in reporter gene assays. In human tumours ZEB1 is
upregulated in invasive cancer cells at the tumour–host interface,
which is accompanied by downregulation of PKP3 expression
levels. Hence, the transcriptional repression of PKP3 by ZEB1
contributes to ZEB1-mediated disintegration of intercellular
adhesion and epithelial to mesenchymal transition.
 2007 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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The functional and structural integrity of epithelial tissues is
based upon apico-basal polarity of epithelial cells, which in
turn depends on a number of intercellular junctions, including
gap junctions, tight junctions, adherens junctions and desmo-
somes [1]. Desmosomes, also known as maculae adherens,
are intermediate ﬁlament-attached adhering junctions which
contribute to strong intercellular adhesion and confer resis-
tance to mechanical stress [2,3]. The organization of desmo-
somes closely resembles that of E-cadherin type adherens
junctions. Desmosomes contain clusters of cadherin-type
transmembrane proteins, the Desmogleins (Dsg) and Desmo-*Corresponding authors. Fax: +43 1 4277 9616 (A. Eger).
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cellular adhesion by homo- and heterophilic interactions [4].
The cadherin-associated plaque region contains Plakoglobin
and Desmoplakin, constitutive desmosomal components medi-
ating the linkage to the intermediate ﬁlament network.
The Plakophilins (PKPs) represent an important group of
proteins integral to the inner desmosomal plaque area. They
belong to the p120ctn subfamily of armadillo-related proteins
sharing a characteristic series of armadillo domain repeats of
about 45 amino acids [5,6]. The diﬀerent members designated
as Plakophilin 1–3 (PKP1–3) interact with the desmosomal
cadherins as well as with the cytoskeletal linker proteins Des-
moplakin and Plakoglobin, and show distinct expression pat-
terns and eﬀects on desmosomal adhesion [6]. Their
numerous interactions within the desmosomal plaque suggest
that they act as scaﬀolding proteins required for proper desmo-
some assembly. In addition, Plakophilins may also be involved
in transducing signals in response to stimuli from the cellular
environment, since nuclear localization has been reported for
all three Plakophilins [5,7–9]. Together, these data establish
the Plakophilins as critical regulators of desmosome assembly
and function. However, upstream signalling molecules that
regulate the expression and/or function of the diﬀerent Plako-
philins in epithelial tissue homeostasis remain to be identiﬁed.
Here we report that ZEB1, a potent transcriptional repressor
of E-cadherin directly represses the expression of PKP3 in
invasive human cancer cells. ZEB1 binds to the PKP3 pro-
moter in vivo and strongly reduces corresponding promoter
activities in reporter gene assays. In human colon cancer spec-
imens membranous PKP3 is expressed mainly in the diﬀerenti-
ated bulk tumour region but is downregulated in invasive cells
upregulating ZEB1.2. Materials and Methods
2.1. Cell culture and Aﬀymetrix Gene Chip analyses
MDA-MB-231, MCF7, and EpH4 cells were cultivated as described
previously [11]. For generation of E-cadherin expressing cell clones,blished by Elsevier B.V. All rights reserved.
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lected with 800 lg/ml Geneticin (G418; Invitrogen, Carlsbad, USA).
RNA isolation, RNA quality control, RNA labeling, hybridization
on Aﬀymetrix Gene Chips (Human Genome U133 Plus 2.0) and data
acquisition including fold-change analyses were done as described [10].2.2. Reporter gene assays
Transient reporter experiments in human MCF7 and mouse EpH4
mammary epithelial cells were done as described previously [11].2.3. RT–PCR
Total mRNA and cDNA was prepared as described previously [11].
PCR primers used were for PKP3: forward 5 0-CTCGGAACGCTAG-
GAACAAG-30, reverse 5 0-AAGTCCTCCTTCCGATAGCC-30; E-
cadherin: forward 5 0-TGGAGGAATTCTTGCTTTGC-30, reverse
5 0-CGTACATGTCAGCCAGCTTC-30; Actin: forward 5 0-ATCTGG-
CACCACACCTTCTAC-30, reverse 5 0-CAGCCAGGTCCAGACG-
CAGG-3 0.
2.4. Antibodies
The following antibodies (Abs) were used: mouse monoclonal Ab to
E-cadherin (BD Biosciences, Franklin Lakes, NJ, USA); goat poly-
clonal Ab to ZEB1 (ZEB-E20, Santa Cruz Biotechnology Inc., Santa
Cruz, CA, USA); mouse monoclonal Ab to PKP3 (23E3/4, [28];
Zymed Laboratories, South San Francisco, CA, USA); rabbit poly-
clonal Ab against Actin (Sigma, St. Louis, USA); secondary Abs cou-
pled to Alexa Fluor 488 (Molecular Probes Inc., Eugene, OR, USA),
Texas Red or peroxidase (Jackson Laboratories, West-Grove, USA).
2.5. Immunoﬂuorescence microscopy and immunoblotting
Cells were ﬁxed in 2.5% formaldehyde (Merck Inc., Whitehouse Sta-
tion, NJ, USA) and processed for immunoﬂuorescence microscopy as
described [12]. Immunoblotting of total cell lysates obtained from
equal amounts of cells was performed as described previously [12].Fig. 1. Knock down of ZEB1 causes upregulation of PKP3 expression.
(A) RNAi-mediated knock down of ZEB1 in MDA-MB-231 breast
cancer cells. Three days after treatment with either ZEB1-speciﬁc (si-
ZEB1) or unspeciﬁc scrambled (si-Control) siRNAs total RNA was
harvested and processed for Aﬀymetrix Gene Chip analysis.
Diagram shows relative-change of mRNA levels of ZEB1 and PKP3
after ZEB1-speciﬁc knock down compared to cells treated with
scrambled siRNA (si-Control). (B) PKP3 and E-cadherin mRNA
levels after ZEB1 knock down. mRNA levels were analysed by semi-
quantitative RT-PCR three days after ZEB1 knock down (see A).
Actin was included for normalization. (C) Protein levels of PKP3, E-
cadherin and ZEB1 after knock-down of ZEB1. For immunoblotting
cells were treated with siRNAs as indicated in (A). Total MDA-MB-
231 cell lysates were separated by SDS–PAGE and immunoblots were
performed using antibodies to ZEB1, PKP3, E-cadherin and Actin
(loading control).2.6. Immunohistochemistry
Formalin-ﬁxed, paraﬃn-embedded colorectal adenocarcinomas
were obtained from surgical resection specimens. Tumour sections
were deparaﬃnized in xylene, rehydrated in alcohols, and washed twice
with water. Samples were boiled in 0.01 M citrate buﬀer (pH 6.0) for
30 min and subjected to immunohistochemistry employing the Vecta-
stain ABC Kit (Vector Laboratories, Burlingame, CA).
2.7. Chromatinimmunoprecipitations (ChIPs)
ChIP analyses were performed according to the instructions of the
ChIP Assay Kit from Upstate Biotechnology (Lake Placid, NY,
USA) as described previously [11]. Primers used were: PKP3 ChIP1
forward: 5 0-CCCAAATTCCACCTTAAGCA-3 0, reverse: 5 0-CGCC-
TCCAAACCCAACTAT-3 0; ChIP2 forward: 5 0-ACCTGTTAGC-
AGCTGCAATTT-3 0, reverse 5 0-GAAGGGGGCGTCTGTCTG-30.
2.8. RNA inhibition experiments
ZEB1-speciﬁc siRNA experiments were performed as described pre-
viously [11].3. Results
3.1. Knock down of ZEB1 in invasive cancer cells causes re-
expression of PKP3
Deconstruction of junctional complexes allows diﬀerentiated
epithelial cells to convert to a motile ﬁbroblastoid phenotype
during embryonic development and physiological events in
the adult organism [13,14]. This process, generally termed epi-
thelial-mesenchymal transition (EMT), is also pathologically
activated during cancer cell invasion and metastasis [15,16].
Recently, we have identiﬁed the transcription factor ZEB1
(dEF1, TCF8, AREB6) as a direct transcriptional repressor
of E-cadherin and a potent inducer of EMT in human breastcancer cells [11] (see also Fig. 1B and C). In addition, depletion
of ZEB1 in dediﬀerentiated and metastatic cancer cells by
RNA interference not only restored E-cadherin expression
but also caused the reestablishment of epithelial features
including the partial formation of adherens and tight junctions
[11]. These data suggest that ZEB1 may regulate various genes
critically involved in the formation of epithelial adhesion com-
plexes.
In order to determine the function of ZEB1 during cancer
progression, we speciﬁcally knocked down ZEB1 in invasive
and dediﬀerentiated MDA-MB-231 cancer cells expressing
high levels of endogenous ZEB1 and lacking all junctional
adhesion complexes, and identiﬁed de-repressed genes by
Aﬀymetrix Gene Chip analyses. Among the genes whose
transcript levels were signiﬁcantly upregulated upon ZEB1
depletion, we detected the desmosmal protein PKP3
(Fig. 1A). RT-PCR experiments using cDNA samples from
three independent siRNA knockdown experiments conﬁrmed
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amounts of PKP3 transcripts were detected in control cells
treated with unspeciﬁc scrambled siRNAs, whereas strong
expression was observed upon speciﬁc depletion of ZEB1
(Fig. 1B, one representative example is shown). Next we ana-
lysed whether the increase in PKP3 transcripts concomitantly
led to the expression of functional protein products. MDA-
MB-231 cells were treated with unspeciﬁc or ZEB1-speciﬁc
siRNAs for three days and total cell lysates were probed for
PKP3 protein by immunoblotting. Only minor amounts of
PKP3 were detected in MDA-MB-231 control cells, whereas
ZEB1 depletion caused strong upregulation of PKP3 protein
levels (Fig. 1C).
Immunoﬂuorescence microscopy conﬁrmed that PKP3 was
upregulated in ZEB1-depleted MDA-MB-231 cells and located
to spot-like structures in the cytoplasm or at the lateral plasma
membrane (Fig. 2). In contrast, control cells exhibited only
weak and diﬀuse cytoplasmic stainings (Fig. 2). However, de-Fig. 2. PKP3 is partially relocalized to the plasma membrane upon
ZEB1 knock-down. For immunoﬂuorescence microscopy MDA-MB-
231 cells were treated with ZEB1-speciﬁc (si-ZEB1) or unspeciﬁc
scrambled (si-Control) si-RNAs for three days, ﬁxed with formalde-
hyde and stained with PKP3, E-cadherin, Desmoplakin and ZO1
speciﬁc antibodies. Bars, 10 lm.ﬁned dotted staining patterns along the whole lateral mem-
brane, which are typical for desmosomal structures in fully
polarized epithelia, could not be observed. Similar observa-
tions were made regarding the expression and intracellular
localization of the desmosomal plaque protein Desmoplakin
(Fig. 2). The lack of fully diﬀerentiated desmosomes might
be due to the short-term inhibition of ZEB1 in the transient
siRNA experiments (3 days siRNA treatment). At this stage
the tight junction marker ZO1 only partially accumulated at
the plasma membrane (Fig. 2). Alternatively, critical desmo-
somal components might still be missing and/or limiting in
ZEB1-depleted MDA-MB-231 cells preventing complete
assembly of desmosomes. Taken together, the knock down
of ZEB1 caused strong derepression of PKP3 on both the
mRNA and protein level and caused partial relocalization of
PKP3 to the lateral plasma membrane.3.2. Expression of E-cadherin is not suﬃcient to induce PKP3
expression
Besides its major structural role in epithelial cell-cell adhe-
sion E-cadherin can critically inﬂuence intracellular signalling
pathways such as Wnt and receptor tyrosine kinase signalling
[17]. Moreover, many reports demonstrated that ectopic E-
cadherin expression is suﬃcient to confer epithelial diﬀerentia-
tion to ﬁbroblasts and dediﬀerentiated cancer cells [18]. As
re-expression of functional E-cadherin is one of the hallmarks
of ZEB1 knock down in MDA-MB-231 cancer cells [11], we
investigated whether E-cadherin expression may be suﬃcient
to induce PKP3 expression in a ZEB1 independent manner.
We generated MDA-MB-231 cells stably expressing GFP-
tagged E-cadherin, which has been shown previously to be
functional and confer adhesion to E-cadherin-negative mesen-
chymal cells [19]. Ectopically expressed E-cadherin was en-
riched at sites of cell to cell contacts but accumulated also in
the cytoplasm (Supplementary Fig. 1A). However, the cells
did not display polarized and diﬀerentiated epithelial features,
but formed only irregularly structured and weakly adhesive
cell clusters (Supplementary Fig. 1A). In these cells PKP3
expression was induced neither at the mRNA nor at the pro-
tein level (Supplementary Fig. 1A and B). Expression of E-cad-
herin also did not alter ZEB1 expression levels in MDA-MB-
231 cells (data not shown). Thus, expression of E-cadherin
alone was not suﬃcient to upregulate PKP3 transcript or pro-
tein levels.3.3. ZEB1 physically associates with the PKP3 promoter and
represses its activity
Next we analysed whether PKP3 represents a direct bona ﬁde
target gene of ZEB1 in MDA-MB-231 cancer cells. ZEB1 was
previously shown to speciﬁcally interact with E-box elements
in the proximal promoter region of target genes such as E-cad-
herin [11,20,21]. Hence, we searched the human and mouse
proximal PKP3 promoter regions for the presence of E-box
elements (5 0-CACCTG-3 0). Within the ﬁrst 4 kbp upstream
of the PKP3 transcription initiation site we detected six and se-
ven E-box consensus sites in the human and mouse promoter,
respectively, of which the two E-box elements closest to the ini-
tiation of transcription were highly conserved between both
species (Fig. 3A and B; Fig. 4A; Supplementary Fig. 2). On
the other hand two additional highly conserved stretches
located further upstream did not contain E-box elements
Fig. 3. ZEB1 directly associates with the PKP3 promoter and represses its activity. (A) Scheme of the human PKP3 promoter. Relative positions of
E-boxes are depicted as black bars along the ﬁrst four kbp of the human PKP3 promoter. (B) The two proximal E-boxes (shaded) close to the
transcription initiation site are conserved in the human and mouse PKP3 promoter. (C) ZEB1 physically interacts with the human PKP3 promoter.
ZEB1 associated chromatin fragments derived from MDA-MB-231 cells were pulled down in chromatin immunoprecipitation (ChIP) experiments.
PKP3 promoter regions were ampliﬁed by PCR (see ChIP1 and ChIP2 in A). Input conﬁrms equal chromatin loading. Lane ZEB1: ZEB1-speciﬁc
antibody; Lane Control: unspeciﬁc goat antibody. (D) ZEB1 represses the human PKP3 promoter activity. Human ZEB1 or Snail1 expression vector
or control vector (p120ctn) were transfected into human epithelial MCF7 cells together with one of the two human PKP3 promoter constructs
depicted in (A) (hPKP3-prom1 and hPKP3-prom2). Relative repression by ZEB1 and Snail1 (Sna1) is shown by mean values of four independent
measurements compared to control vector. Bars represent standard errors on the mean.
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Hence, we performed chromatin immunoprecipitation (ChIP)
assays to investigate whether ZEB1 can directly associate with
the conserved E-box elements in the human PKP3 promoter
in vivo. ZEB1-associated chromatin was immunoprecipitated
from human MDA-MB-231 cells that express high levels of
endogenous ZEB1 [11] using an antibody speciﬁcally recogniz-
ing the N-terminal domain of ZEB1 [11,22]. Chromatin frag-
ments associated with ZEB1 were analysed for the presence
of PKP3 promoter sequences by PCR using primers that either
span the two conserved proximal E-boxes (143/+43; ChIP1)
or E-box 6 located further upstream (3800/3670; ChIP2) in
the human PKP3 promoter (Fig. 3A). As depicted in Fig. 3C
the ZEB1 antibody consistently pulled down chromatin frag-
ments containing the two proximal E-boxes elements, whereas
fragments containing the most upstream E-box could not be
detected. In addition, unspeciﬁc control antibodies did not pre-
cipitate any PKP3 promoter sequences (Fig. 3C).
To determine whether binding of ZEB1 to the proximal
PKP3 promoter region in vivo is suﬃcient to repress the hu-
man PKP3 promoter activity, we generated two diﬀerent but
overlapping luciferase reporter constructs (496/+43,hPKP3-prom1 and 934/+43, hPKP-prom2), both containing
the proximal conserved E-boxes of the human promoter. These
constructs were transfected into human MCF7 epithelial cells,
which express high levels of endogenous PKP3 (Supplemen-
tary Fig. 1), together with a human ZEB1 expression vector
or a control vector expressing an unrelated protein (p120ctn)
as well as a b-galactosidase vector for normalization of trans-
fection eﬃciency and viability. Compared to the control vec-
tor, expression of ZEB1 caused a signiﬁcant repression of
both human PKP3 promoter constructs (Fig. 3D). Similar to
ZEB1 the transient overexpression of the E-box binding
repressor Snail1 also interfered with the activity of the human
PKP3 promoter.
In order to investigate whether the activity of the mouse
PKP3 promoter is also aﬀected by ZEB1, we tested four diﬀer-
ent mouse PKP3 promoter constructs in reporter gene assays
(Fig. 4A). Two proximal shorter fragments encompassing the
regions 411/2 (with only the two conserved E-boxes; named
mPKP3-prom1) or 877/2 (with three E-boxes; named
mPKP3-prom2), and two longer fragments ranging from
3177 to 2 (with six E-boxes; named mPKP3-prom3) and
3808 to 2 (with seven E-boxes; named mPKP3-prom4)
Fig. 4. ZEB 1 represses the activity of the mouse PKP3 promoter. (A) Scheme of the ﬁrst four kbp of the mouse PKP3 promoter. E-boxes are
indicated by black bars. The position of the four promoter fragments are shown below the scheme (mPKP3-prom1-4). (B) Reporter assays were
performed as indicated in Fig. 3 using a mouse full-length ZEB1 expression vector and EpH4 murine mammary epithelial cells.
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described above using a full-length mouse ZEB1 expression
construct [11]. Albeit ZEB1 repressed the activity of all four
PKP3 promoter regions, repression was particularly eﬀective
with the two shorter reporter constructs containing mainly
the proximal conserved E-boxes (Fig. 4B). These data indicate
that in analogy to the human PKP3 promoter, the proximal E-
boxes were necessary and suﬃcient to mediate repression by
ZEB1. Only weak repressive eﬀects were observed for the long-
er constructs (Fig. 4B). Hence, the longer promoter fragments
might additionally contain regulatory elements that partially
relieve the repressive eﬀects of ZEB1. Taken together, our data
demonstrate that endogenous ZEB1 can directly associate with
the proximal PKP3 promoter in undiﬀerentiated cancer cells
and partially repress both human and mouse PKP3 promoter
activities. Repression is mediated by conserved proximal E-
box elements close to the transcription initiation site.
3.4. ZEB1 represses PKP3 during cancer cell invasion in vivo
To determine whether ZEB1 is able to repress PKP3 expres-
sion during cancer cell invasion in human tumours we per-
formed double-immunohistochemical analyses of 10 paraﬃn-
embedded human colon cancer specimens using antibodies to
PKP3 and ZEB1. Colon cancer represents a suitable cancer
type to study ZEB1 function in vivo, as ZEB1 has already been
implicated in the repression of basal lamina components in co-
lon tumours [23].
Immunohistochemistry revealed that within the diﬀerenti-
ated bulk tumour area PKP3 localized primarily to the plasma
membrane of cancer cells (Fig. 5A, violet stain, arrows).
Accordingly, these cells express high amounts of E-cadherin
and cytokeratin emphasizing their diﬀerentiated epithelial phe-
notype (data not shown). These diﬀerentiated cancer cells com-
pletely lacked detectable ZEB1 expression (Fig. 5A, no brown
stain in cells indicated by arrows). However, ZEB1 accumu-
lated in the nuclei of a large number of tumour-associated stro-
ma cells (Fig. 5A, brown stain, arrowheads), whereas innormal colon stroma ZEB1 positive cells were only rarely de-
tected (data not shown). Within the stroma ZEB1 might be
speciﬁcally expressed in ﬁbroblasts and partially in activated
ﬁbroblasts expressing Smooth Muscle Actin (SMA) (Fig. 5B,
SMA, violet; ZEB1, brown. Arrowheads indicate colocaliza-
tion of SMA and ZEB1). At present one can only speculate
whether some of the ZEB1 positive stromal ﬁbroblasts might
have directly developed from epithelial cancer cells through a
bona ﬁde ZEB1-dependent EMT (compare also with [32]).
Colon tumours showed deﬁned areas of strong invasion,
where loosely attached or single cancer cells invade the under-
lying stroma (Fig. 5C, Hematoxylin/Eosin stain of invasive co-
lon cancer area). In contrast to the bulk tumour area, ZEB1
was strongly upregulated in distinct invading cancer cells at
the tumour–host interface. Upregulation of ZEB1 was clearly
visible in eight out of 10 cancer specimens (Fig. 5D, brown
stain, arrowheads). Based on nuclear and cellular morpholo-
gies the ZEB1-positive cancer cells were clearly diﬀerent from
the ZEB1-expressing stroma cells (compare arrowhead marked
cells in Fig. 5A, C and D). ZEB1 expression was always
accompanied by defects in intercellular adhesion and loss of
membrane associated PKP3. However, the cells still exhibited
a rudimentary cytoplasmic PKP3 pool, which directly proved
their epithelial origin (Fig. 5D).
In conclusion, signiﬁcant levels of membrane-bound PKP3
can only be found in the diﬀerentiated main tumour mass of
colorectal cancers barely expressing any ZEB1, whereas upreg-
ulation of ZEB1 at the invasive front was accompanied by
downregulation of PKP3 protein levels and loss of intercellular
adhesion.4. Discussion
4.1. PKP3 is directly repressed by ZEB1 in human cancer cells
In the present study we demonstrate that ZEB1 directly re-
presses the transcription of the desmosomal component
Fig. 5. ZEB1 and PKP3 localization in human colon cancer. (A) Colon cancer specimens were double-stained for ZEB1 (brown stain) and PKP3
(violet stain). Left panel, overview of diﬀerentiated bulk tumour area. Right panel, higher magniﬁcation of diﬀerentiated area. PKP3 is expressed in
diﬀerentiated regions of the tumour (violet stain, arrows), whereas ZEB1 is mostly detected in tumour-associated stroma cells (brown stain,
arrowheads). (B) Double staining of ZEB1 (brown) and Smooth Muscle Actin (violet). Note that some of the activated tumour-associated ﬁbroblasts
express nuclear ZEB1. (C) Invasive area of colon tumour stained with Hematoxylin/Eosin. (D) Upregulation of ZEB1 in invasive cancer cells at the
tumour–host interface (brown stain, arrowheads). ZEB1 expression is accompanied by downregulation of PKP3 (violet stain in cells marked with
arrowheads). Note that residual PKP3-speciﬁc staining is still detectable in the cytoplasm of ZEB1 expressing cells. Bars, 120 lm (A,B,C left) or
30 lm (A,B,C, right and D).
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interference (RNAi) was suﬃcient to upregulate expression
of PKP3 at the mRNA and protein level. Derepression of
PKP3 was independent of the expression and function of the
major intercellular adhesion protein E-cadherin. Second,
ZEB1 was able to physically associate with the proximal
PKP3 promoter in vivo and to partially repress the activity
of corresponding promoter fragments of the human and
mouse PKP3 promoter in reporter gene assays. Third, upregu-
lation of ZEB1 in human tumours correlated with cancer cell
invasion and was accompanied by a signiﬁcant downregula-
tion of PKP3 protein levels.
Currently it is unclear which signalling pathways contribute
to upregulation of ZEB1 in cancer cells at the tumour–host
interface. Paracrine signalling mechanisms, such as release of
tumour necrosis factor (TNF) a or transforming growth factor
(TGF) b by tumour associated macrophages or other stroma
cells might cause upregulation of ZEB1 in particular cancer
settings [24–27].4.2. ZEB1 disrupts desmosomal adhesion during EMT
PKP3 belongs to the armadillo repeat protein family and is
broadly expressed in most simple and stratiﬁed epithelial tis-
sues except for hepatocytes and hepatocellular carcinomas
[5,6]. Regarding interactions with desmosomal components
PKP3 exhibits the broadest repertoire among the plakophilins,
as it directly interacts with Plakoglobin, the cytoskeletal linker
protein Desmoplakin and all desmosomal cadherins [28]. Con-
sidering the extensive crosslinking capacity of PKP3 within the
desmosmal plaque, downregulation of its expression by ZEB1
is likely to impair desmosome maturation and stability. In
addition, upregulation of ZEB1 in cancer cells also aﬀects
the expression of other desmosomal components such as Des-
moplakin, Desmogleins and Desmocollins (Aigner and Eger,
unpublished results). Hence ZEB1 can simultaneously aﬀect
the expression of diﬀerent desmosomal proteins, albeit it is un-
clear at present whether ZEB1 can repress the expression of all
these desmosomal genes in a direct manner similar to PKP3.
Interestingly, the E-cadherin repressors Snail1 and SIP1
(ZEB2, a homologue of ZEB1) have also been reported to re-
press the expression of individual Plakophilins [29,30]. Upon
overexpression in colon cancer cell lines Snail1 speciﬁcally re-
pressed the transcription of PKP2, whereas SIP1 aﬀected
expression of PKP2 as well as Desmoplakin. Therefore, the
multiple E-cadherin repressors may induce downregulation
of distinct sets of epithelial target genes, which might depend
on the cellular context and/or the environmental settings of
malignant tissues. However, at present we cannot exclude the
existence of a hierarchy of and/or crosstalk between the diﬀer-
ent E-cadherin repressors in the same cancer type.
In MDA-MB-231 cells the expression of Snail1 is signiﬁ-
cantly lower than the expression of ZEB1 [11] and knock-down
of Snail in these cells is not accompanied by epithelial re-diﬀer-
entiation and upregulation of epithelial marker proteins such
as PKP3 (our unpublished results). However, strong transient
overexpression of Snail1 in MCF7 cells was suﬃcient to inter-
fere with the promoter activity of PKP3. Hence, expression
levels of the diverse E-cadherin repressors as well as the
availability of cofactors might additionally be critical in deter-
mining their overall repressive capacity and target gene speci-
ﬁcity.Extensive expression proﬁling experiments in diﬀerent can-
cer tissues and cell models are still needed to precisely unravel
the gene expression networks established by the E-cadherin
repressors ZEB1, SIP1/ZEB2, Snail1, Snail2 (Slug), and E47
in the course of EMT and cancer cell invasion.
In summary, ZEB1 not only aﬀects the formation of adher-
ens junctions by repressing its major constituent E-cadherin
[11], but also induces the disassembly of desmosomal struc-
tures that normally provide epithelial sheets with additional
adhesive strength and resistance to mechanical stress [2,31].
These data provide ﬁrst experimental evidence of how ZEB1
simultaneously and coordinately remodels epithelial adhesion
complexes in order to disrupt epithelial polarity and trigger
EMT enabling individual tumour cells to escape from bulk tu-
mour areas.
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